Lakewood-Amedex's Series C Round

Lakewood-Amedex raised a round of funding on June 18, 2014.

Lakewood-Amedex is a biopharmaceutical company developing a broad portfolio of innovative novel-approach anti-infective products in the treatment of serious infectious diseases, improving patient outc…

Articles about Lakewood-Amedex's Series C Round: